We are live on ! Find out more
A

Abingworth Portfolio holdings

AUM $307M
1-Year Est. Return 93.47%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+93.47%
3 Year Est. Return
+184.38%
5 Year Est. Return
+342.7%
10 Year Est. Return
–
AUM
$130M
AUM Growth
–
Cap. Flow
+$129M
Cap. Flow %
99.53%
Top 10 Hldgs %
99.79%
Holding
11
New
11
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AMRN
Amarin Corp
AMRN
+$55.8M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$24.7M
3
SUPN icon
Supernus Pharmaceuticals
SUPN
+$21.2M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$8.33M
5
ACHV icon
Achieve Life Sciences
ACHV
+$6.13M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 75.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRN
1
Amarin Corp
AMRN
$292M
$46.8M 36.03%
+404,374
New +$55.8M
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$30.5M 23.47%
+1,240,917
New +$24.7M
SUPN icon
3
Supernus Pharmaceuticals
SUPN
$2.77B
$23.2M 17.84%
+3,600,000
New +$21.2M
ALNY icon
4
Alnylam Pharmaceuticals
ALNY
$36.5B
$9.69M 7.45%
+313,053
New +$8.33M
ACHV icon
5
Achieve Life Sciences
ACHV
$659M
$5.92M 4.55%
+274
New +$6.13M
CEMP
6
DELISTED
Cempra, Inc.
CEMP
$5.59M 4.3%
+714,285
New +$4.94M
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
$4.02M 3.09%
+291,902
New +$3.74M
ANTH
8
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$1.73M 1.33%
+54,749
New +$2.04M
HPTX
9
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.38M 1.06%
+62,500
New +$1.37M
GWPH
10
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$879K 0.68%
+102,200
New +$905K
ZLCS
11
DELISTED
ZALICUS INC COM NEW
ZLCS
$268K 0.21%
+78,967
New +$283K

Similar funds

AAM
Arabesque Asset Management London, United Kingdom $296M AUM 15.19% 1-Year Est. Return
EP
Equius Partners Novato, California $324M AUM 8.27% 1-Year Est. Return
LDFR
Lehman & Derafelo Financial Resources Media, Pennsylvania $337M AUM 8.16% 1-Year Est. Return
MPAM
Monarch Partners Asset Management Boston, Massachusetts $339M AUM 2.52% 1-Year Est. Return
MAG
Mass Ave Global New York $342M AUM 20.58% 1-Year Est. Return
CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
GTCM
Gyon Technologies Capital Management Denville, New Jersey $267M AUM 11.62% 1-Year Est. Return
ACMV
August Capital Management VII Palo Alto, California $265M AUM 26.86% 1-Year Est. Return

Abingworth's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Abingworth, which disclosed 11 positions worth $130M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Amarin Corp: 404,374 shares worth $46.8M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets.

  • Abingworth's largest Q2 2013 buy was Amarin Corp: 404,374 shares worth $46.8M.
  • Abingworth's ten largest holdings make up 100% of its $130M portfolio in Q2 2013.
  • Abingworth disclosed 11 positions in Q2 2013, its first 13F filing on record.

Based on Abingworth's 13F filing for Q2 2013, filed 14 Aug 2013.